RyCarma Therapeutics
Pre-clinicalDecades of foundational research have made it possible to drug ryanodine receptors (RyRs), ion channels that regulate the intracellular flow of calcium in nearly all cell types and are essential for muscle contraction.
Founded
2020
Focus
Small Molecules
About
Decades of foundational research have made it possible to drug ryanodine receptors (RyRs), ion channels that regulate the intracellular flow of calcium in nearly all cell types and are essential for muscle contraction.
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile